You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Harvard Business School
McKesson
Baxter
Express Scripts

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Claims for Patent: RE29980

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: RE29980
Title: Method of obtaining urokinase
Abstract:A method of obtaining urokinase directly from human urine comprising contacting human urine with an acrylonitrile polymer of a unique porous structure formed at the time of polymerization for formation of the polymer and having a porosity of not less than 10% and a specific surface area of .Iadd.not less than .Iaddend.5 m.sup.2 /g. and subsequently eluting the urokinase adsorbed on the polymer. The acrylonitrile polymer employed in the method of the present invention has an excellent adsorption activity to urokinase and therefore, with use of an extremely small amount of the adsorbent, the satisfactory results can be obtained. Moreover, the porous polymer of the present method can also be utilized for purification of low purity crude urokinase obtained by the prior art methods.
Inventor(s): Abe; Tsutomu (Fuji, JP), Hashino; Yasuo (Fuji, JP), Kobayashi; Hidehiko (Fuji, JP)
Assignee: Asahi Kasei Kogyo Kabushiki Kaisha (Osaka, JP)
Application Number:05/856,057
Patent Claims:1. A method of obtaining urokinase from human urine comprising contacting human urine with an acrylonitrile polymer of a porous structure having a porosity of not less than 10% and a specific surface area of .Iadd.not less than .Iaddend. 5 m.sup.2 /g. to adsorb urokinase onto said acrylonitrile polymer, said porous structure having been formed at the time of polymerization for formation of the polymer, and subsequently eluting the urokinase from said acrylonitrile polymer having the urokinase adsorbed thereon.

2. A method according to claim 1 wherein said acrylonitrile polymer is a homopolymer or a copolymer of acrylonitrile.

3. A method according to claim 2 wherein said polymer is a copolymer and contains at least 30% by weight of acrylonitrile based on the copolymer of acrylonitrile.

4. A method according to claim 1 wherein said porosity is 10 to 50%.

5. A method according to claim 1 wherein said specific surface area is 5 to 100 m.sup.2 /g.

6. A method according to claim 1 wherein said acrylonitrile polymer is one obtained by solution polymerization, suspension polymerization or emulsion polymerization of a corresponding monomer in a liquid medium selected from the group consisting of water, an alcohol, a hydrocarbon, an ester, a nitrile and mixtures thereof, said monomer and said liquid medium being employed in an amount ratio of 1:2 to 1:10.

7. A method according to claim 6 wherein said liquid medium is an aqueous system containing at least 50% by volume of water.

8. A method according to claim 1 wherein said acrylonitrile polymer is in the form of an aqueous slurry or a powder.

9. A method according to claim 1 wherein said acrylonitrile polymer is in the form of a coating on a support.

10. A method according to claim 1 wherein said acrylonitrile polymer is in the form as coagulated.

11. A method according to claim 1 wherein said acrylonitrile polymer is employed in an amount of 0.1 to 0.3 g. per liter of the human urine.

12. A method according to claim 1 wherein the eluting is effected using an aqueous alkali solution.

13. A method according to claim 12 wherein said aqueous alkali solution is an aqueous solution of a member selected from the group consisting of ammonia, an amine and sodium hydroxide.

Summary for Patent:   Start Trial

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan50-81969Jul 4, 1975

Details for Patent RE29980

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 001 1978-01-16   Start Trial Asahi Kasei Kogyo Kabushiki Kaisha (Osaka, JP) 1996-05-01 DISCN search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 002 1978-01-16   Start Trial Asahi Kasei Kogyo Kabushiki Kaisha (Osaka, JP) 1996-05-01 DISCN search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 003 1978-01-16   Start Trial Asahi Kasei Kogyo Kabushiki Kaisha (Osaka, JP) 1996-05-01 DISCN search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.